DOCUMENT RESOURCES FOR EVERYONE
Documents tagged
CardioVascular Research Foundation Asan Medical Center Seung-Jung Park, MD, PhD on behalf of the ZEST investigators Comparison of the Efficacy and Safety.
Documents CardioVascular Research Foundation Asan Medical Center Seung-Jung Park, MD, PhD on behalf of the...

Slide 1CardioVascular Research Foundation Asan Medical Center Seung-Jung Park, MD, PhD on behalf of the ZEST investigators Comparison of the Efficacy and Safety of Zotarolimus-Eluting…

_ไขมันในเลือดสูง_2553-1_-_reduced_font_4
Documents _ไขมันในเลือดสูง_2553-1_-_reduced_font_4

462505 -2553/1 What is ischaemic heart disease? Ischaemic heart disease (IHD) is also called coronary heart disease (CHD) or coronary artery disease (CAD) Ischaemic refers…

CYPHER® Stent vs. Taxus Stent: Randomized Trials - Adnan Kastrati
Documents CYPHER® Stent vs. Taxus Stent: Randomized Trials - Adnan Kastrati

1. CYPHER ®Stent vs. Taxus Stent: Randomized Trials Kastrati A., et al., ACC 2007 Oral Presentation. 2. The ACC/AHA and ESC Guidelines American College of Cardiology/American…

J. Mehilli, MD, G. Richard, F-J. Neumann, S. Massberg, K-L. Laugwitz, J. Pache, J. Hausleiter, I. Ott, M. Fusaro, T. Ibrahim, A. Schömig, A. Kastrati Deutsches.
Documents J. Mehilli, MD, G. Richard, F-J. Neumann, S. Massberg, K-L. Laugwitz, J. Pache, J. Hausleiter, I....

Slide 1 J. Mehilli, MD, G. Richard, F-J. Neumann, S. Massberg, K-L. Laugwitz, J. Pache, J. Hausleiter, I. Ott, M. Fusaro, T. Ibrahim, A. Schömig, A. Kastrati Deutsches Herzzentrum…

BIOLIMUS-ELUTING STENT WITH BIODEGRADABLE POLYMER VERSUS SIROLIMUS-ELUTING STENT WITH DURABLE POLYMER: A RANDOMISED, NON-INFERIORITY TRIAL Stephan Windecker,
Documents BIOLIMUS-ELUTING STENT WITH BIODEGRADABLE POLYMER VERSUS SIROLIMUS-ELUTING STENT WITH DURABLE...

Slide 1 Slide 2 BIOLIMUS-ELUTING STENT WITH BIODEGRADABLE POLYMER VERSUS SIROLIMUS-ELUTING STENT WITH DURABLE POLYMER: A RANDOMISED, NON-INFERIORITY TRIAL Stephan Windecker,…

ACC/AHA Guidelines STEMI
Documents ACC/AHA Guidelines STEMI

BRAIN STEM SYNDROMES STEMI MANAGEMENT Definition Criteria.. e/o myocardial necrosis in a clinical setting consistent with myocardial ischaemia. Detection of rise &/or…

Seung-Jung Park, MD, PhD on behalf of the ZEST investigators Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent versus Sirolimus-Eluting.
Documents Seung-Jung Park, MD, PhD on behalf of the ZEST investigators Comparison of the Efficacy and Safety.....

Seung-Jung Park, MD, PhD on behalf of the ZEST investigators Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent versus Sirolimus-Eluting Stent and PacliTaxel-Eluting…

Volker Klauss, MD Patrick W. Serruys, Simon Wandel, Pawel Buszman,
Documents Volker Klauss, MD Patrick W. Serruys, Simon Wandel, Pawel Buszman,

LEADERS A Prospective, Randomised, Non-Inferiority Trial Comparing Biolimus-Eluting Stent With Biodegradable Polymer Versus Sirolimus-Eluting Stent With Durable Polymer Volker…

SEA-CORP BC : SEA side and COR pal B ifurcation trials C ooperative study
Documents SEA-CORP BC : SEA side and COR pal B ifurcation trials C ooperative study

BURZOTTA F.1, PAN M.2 (CO-FIRST AUTHOR), TRANI C. 1, MEDINA A. 3, SUÃREZ DE LEZO J. 2, NICCOLI G. 1, ROMERO M. 2, PORTO I. 1, MAZUELOS F. 2, LEONE A.M. 1, MARTIN P. 3, COLUCCIA…

e-BioMatrix-Registry
Documents e-BioMatrix-Registry

e-BioMatrix Registry: A Post Market Registry For The BioMatrix™ Stent P. Urban, J. Berland, D. Hildick-Smith, D.G. Iosseliani, X. Kleber, K. Oldroyd, M. Roffi, M. Valdés,…

Popular Categories
Relevant Tags